DRW Securities’s MacroGenics MGNX Stock Holding History

DRW Securities’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,196	Closed	-$22K	–	1507
2025 Q2	$22K	Buy	+18,196	New	+$26.4K	﹤0.01%	1059
2024 Q3	–	Sell	-13,105	Closed	-$55.7K	–	663
2024 Q2	$55.7K	Buy	+13,105	New	+$128K	﹤0.01%	502

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DRW Securities's MGNX Position: Q3 2025 in Review

DRW Securities sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 18,196 shares — an estimated $22K sold.

DRW Securities first reported a position in MGNX in Q2 2024 and held it in 2 quarters. The position peaked at $55.7K in Q2 2024. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

DRW Securities reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
DRW Securities sold 18,196 MacroGenics shares in Q3 2025, an estimated $22K.
DRW Securities first reported a position in MacroGenics in Q2 2024 and held it in 2 quarters.
DRW Securities's MacroGenics position peaked at $55.7K in Q2 2024.
104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on DRW Securities's 13F filing for Q3 2025, filed 14 Nov 2025.